25. Weakness Flashcards
differential for weakness
Brain
- MS
- Stroke (and think about stroke mimics hypoglycaemia, todd’s paresis, migraine, bell’s palsy)
- Space occupying lesion
- Psychogenic
Spinal Cord
- MS
- Motor neuron disease
- Myelopathy
- Any spinal cord disorder affecting the corticospinal tract eg subacute combined degeneration,
Nerve roots
- Radiculopathy
Peripheral nerves
- Motor neuron disease causing LMN signs
- peripheral neuropathy - motor loss
Neuromuscular junction
- Myasthenia gravis and lambert eaton
Muscle
- Muscular dystrophy
- Muscular breakdown eg rhabdomyolysis
Muscle inflammation and damage eg rhabdomyolysis, polymyositis, dermatomyositis, statin-induced, corticosteroid induced, cushings, addisons
History taking weakness
PC: weakness = onset? where in the body, has the pattern changed? worse at any point in the day? how does it affect ADLs?, improved by rest or movement?
screening for weakness elsewhere: eyelid weakness? double vision? lazy eye? change in vision (eg homonymous hemianopia), facial expression weakness? difficulty getting up from a chair? clumsy? difficulty swallowing?speaking?
associated symptoms: headache, n&v, LOC, changes to voice? dizziness? vertogo? palpitations
MHx: AF, migraines,
DHx: anticoagulants, statins, COCP,
Examination weakness
UL neuro, LL neuro
- any UMN signs?
- pattern of weakness?
Cranial nerve exam
- eye movements?
- visual field defect?
- forehead sparing?
- swallowing issue?
GCS
cerebellar exam
ABCDE
check glucose!! can cause stroke mimic!
UMN signs
Minimal muscle atrophy
Weakness
Hyperreflexia of deep tendon reflexes- as no UMN regulating that reflex
Absent superficial reflex - babinski positive
Hypertonia + or - clonus
Pronator drift
causes of LMN lesions
ALS (may also have UMN)
Peripheral neuropathy motor loss (guillain barre, charcot-marie tooth)
Spinal cord disorders (should also have UMN) that involve:
Injury to axons leaving spinal cord
Injury to anterior horn/grey matter of spinal cord
causes of UMN lesions
Stroke
Infection
Tumour
Damage to white matter/corticospinal tract eg myelopathy, MS
ALS
Injury to brain stem
LMN signs
Muscle atrophy
Flaccid paralysis
No plantar response
Absent tendon reflexes
Fasciculations (single muscle fibres of uninjured LMN stimulated)
test for conversion disorder weakness
hoovers sign
causes of peripheral muscle weakness? signs?
guillian barre
Charcot-marie tooth
lead poisoning
Ascending weakness
“Tripping over feet”
Foot drop
Hyporeflexia
causes of proximal muscle weakness
Corticosteroid-induced proximal myopathy
Statin-induced myopathy
Cushings
Rhabdomyolysis
Polymyositis
Dermatomyositis
Addisons
Muscular dystrophy
Presentation polymyositis and dermatomyositis
Symmetrical, proximal muscle weakness
Raynaud’s
As the disease progresses, other muscles may also become involved, resulting in the following:
Pharyngeal or oesophageal muscles leading to dysphonia and dysphagia.
Respiratory muscles can lead to poor ventilation with type 2 respiratory failure.
Dermatomyositis causes the above plus skin changes eg
Heliotrope rash -which is a lilac discolouration of the eyelid skin in addition to periorbital oedema
first line invetsigation ?inflammatory myopathy
creatinine kinase
invetsigations ?polymypositis/dermatomyositis
creatinine kinase
nerve conduction studies = Electromyography (EMG)
muscle biopsy for definitive
may want to look for underlying malignancy
what enzymes are elevated in demratomyositis and polymyositis
DM and PM turn your muscles into CLAAA (clay):
Creatine kinase
Lactate dehydrogenase
Aldolase
ALT
AST
management polymyositis/dermatmyositis
Corticosteroids
are the mainstay of treatment. They are started at high doses initially, creatanine kinase is then monitored to guide the rate of tapering the dose.
Many patients need an additional immunosuppressant such as methotrexate or azathioprine as a steroid-sparing agent.
Hydroxychloroquine occasionally helps with skin disease in dermatomyositis.
As well as pharmacological therapy, physiotherapy is essential to rehabilitate patients.
define stroke
‘rapidly developing clinical signs of focal (at times global) disturbance of cerebral function, lasting more than 24 hours or leading to death with no apparent cause other than that of vascular origin
define TIA
a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischaemia, without acute infarction
Approach to acute assessment of ?stroke
ABCDE
A
B - is there increased RR? (get blood gas as may be hyperventilating causing resp alk) maintain O2 sats
C - BP- monitor this- in haemorrhagic this is sometimes lowered. Get ECG (may have AF)
D - Don’t forget glucose!!!, reduced GCS may indicate haemorrhagic
E
Focused UL, LL, cranial nerve examination and cerebellar exam
should BP be managed during stroke
ischaemic - usually no, except if:
hypertensive encephalopathy
Hypertensive nephropathy
Hypertensive cardiac failure/myocardial infarction
Aortic dissection
Pre-eclampsia/eclampsia
haemorrhagic - sometimes yes, consult local guidelines
what is the ROSIER score
score used in ?stroke to help ddx between stroke and stroke mimics
a score > 0 means stroke likley
what scoring sytem will you use when assessing ?stroke
ROSIER
what is part of rosier score
LOC -1
seizure -1
asymmetric facial weakness +1
asymmetric arm weakness +1
asymmetric leg weakness +1
speech disturbance +1
visual field defect +1
A stroke is likely if > 0
first line for investigation ?stroke
- non contrast CT
what can a non-contrast CT show you in stroke
ischaemic
- hyperdense artery (often visible immediately)
- low density in grey/white matter (takes time to develop)
haemorrhagic
- hyperdense material (blood) surrounded by low density (oedema)
if a non-contrast CT shows ishcameic stroke/rules out haemorrhage, what other scans might you get?
CT angiography particularly if thrombectomy is being considered
MR angiography
CT perfusion scan or diffusion weighted MRI if looking for salvagable brain tissue
risk factors for ischaemic stroke
OCP is a risk factor
Migraine is a risk factor
AF is a risk factor
Antipsychotics is risk factor
Polycythaemia vera (raised RBC - hyperviscosity)
management ischaemic stroke <6hrs onset
- Aspirin 300mg orally or rectally should be given as soon as possible if a hemorrhagic stroke has been excluded. Continue for 2 weeks.
+ Thrombolysis with alteplase if <4.5 hours since symptom onset
+ Thrombectomy if <6 hours (together with Thrombolysis with alteplase if <4.5 hours) and confirmed occlusion of the proximal anterior circulation demonstrated by CTA or MRA
management of strokes presenting >6 hours after onset of symptoms
- aspirin 300mg orally or rectally should be given as soon as possible if a hemorrhagic stroke has been excluded. Continue for 2 weeks.
CT perfusion or diffusion-weighted MRI
+ thrombectomy if between 6 hours and 24 hours (including wake-up strokes) if there is the potential to salvage brain tissue,
+ consider if proximal posterior circulation
stroke patient. what do you do to manage complications and assess other aspects
DVT risk management: pressure stockings, IPCDs, not dalteparin as it could cause hemorrhagic transformation
SALT referral for swallow screen - make nil by mouth in the meantime
Disability is most commonly measured using the Barthel index (BI)
ECG for ?AF
If AF, ‘anticoagulants should not be started until brain imaging has excluded haemorrhage, and usually not until 14 days have passed from the onset of an ischaemic stroke’
when monitoring stroke pts what are important things to do?
24hr after thrombolysis do another CT to check you haven’t caused haemorrhagic transformation
Young person more likely to get raised ICP as their brain isn’t atrophied so no space t swell - be alert for decrease in GCS
absolute contraindications to thrombolysis
- Previous intracranial haemorrhage
- Seizure at onset of stroke
- Intracranial neoplasm
- Suspected subarachnoid haemorrhage
- Stroke or traumatic brain injury in preceding 3 months
- Lumbar puncture in preceding 7 days
- Gastrointestinal haemorrhage in preceding 3 weeks
- Active bleeding
- Pregnancy
- Oesophageal varices
- Uncontrolled hypertension >200/120mmHg
pharmacological secondary prevention of stroke and TIA
- Clopidogrel
- Aspirin plus modified-release (MR) dipyridamole
- MR dipyridamole
if the cholesterol is > 3.5 mmol/l patients should be commenced on a statin. Atorvostatin 80mg. Many physicians will delay treatment until after at least 48 hours due to the risk of haemorrhagic transformation
If AF, ‘anticoagulants should not be started until brain imaging has excluded haemorrhage, and usually not until 14 days have passed from the onset of an ischaemic stroke’
surgical considerations for secondary prevention of stroke/TIA
consider carotid artery endarterectomy:
- if stroke/tia in carotid territory (eyes, ACA, MCA) and they are not severely disabled
- should only be considered if carotid stenosis > 70% according ECST** criteria or > 50% according to NASCET*** criteria
- Don’t operate on completely blocked as it is sealed so doesn’t embolize and cause strokes
Don’t operate on a asymptomatic carotid